Guangzhou Wondfo Biotech Co Ltd (300482)

Currency in CNY
22.57
+0.23(+1.03%)
Closed·

300482 Financial Summary

Key Ratios

P/E Ratio18.33
Price/Book1.74
Debt / Equity10.21%
Return on Equity9.41%
Dividend Yield1.77%
EBITDA796.73M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2023
01/01
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.12%
Dividend Yield
1.77%
Industry Median 1.87%
Annualised payout
0.40
Paid unevenly
5-Years Growth
+15.78%
Growth Streak

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 25.08
(+11.14% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
0.39 / --
Revenue / Forecast
800.00M / --
EPS Revisions
Last 90 days

FAQ

What were Guangzhou Wondfo Biotech Co Ltd's earnings for the latest quarter?

The Guangzhou Wondfo Biotech Co Ltd EPS (TTM) is 1.12. Guangzhou Wondfo Biotech Co Ltd reported sales of 800.28, net income of 189.14, and EPS of 0.39 for the latest quarter.

What was Guangzhou Wondfo Biotech Co Ltd's net income for the latest quarter?

Guangzhou Wondfo Biotech Co Ltd's net income for the latest quarter was 189.14.

How did Guangzhou Wondfo Biotech Co Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 883.45 in the previous quarter to 800.28 in the latest quarter, and net income moved from 125.69 to 189.14 compared to the previous quarter.

What is Guangzhou Wondfo Biotech Co Ltd's net profit margin on a TTM basis?

Guangzhou Wondfo Biotech Co Ltd's trailing twelve months (TTM) net profit margin is 18.33%.

How does Guangzhou Wondfo Biotech Co Ltd's debt to equity ratio compare to industry standards?

Guangzhou Wondfo Biotech Co Ltd's total debt-to-equity ratio is 10.21%.

What is Guangzhou Wondfo Biotech Co Ltd's return on investment on a TTM basis?

Guangzhou Wondfo Biotech Co Ltd's trailing twelve months (TTM) return on investment (ROI) is 9.41%.

Did Guangzhou Wondfo Biotech Co Ltd gain or lose cash last quarter?

In the latest quarter, Guangzhou Wondfo Biotech Co Ltd's net change in cash was -522.02 million.

What were Guangzhou Wondfo Biotech Co Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, Guangzhou Wondfo Biotech Co Ltd reported total assets of 7,182.55 million and total liabilities of 661.55 million.

How has Guangzhou Wondfo Biotech Co Ltd's total revenue grown this year?

Guangzhou Wondfo Biotech Co Ltd's total revenue was 883.45 in the previous quarter and 800.28 in the latest quarter.

What is Guangzhou Wondfo Biotech Co Ltd's gross margin on a TTM basis?

Guangzhou Wondfo Biotech Co Ltd's trailing twelve months (TTM) gross margin is 63.92%.

What was Guangzhou Wondfo Biotech Co Ltd's revenue per share for the latest quarter?

Guangzhou Wondfo Biotech Co Ltd's revenue per share for the latest quarter was 6.47.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.